227 related articles for article (PubMed ID: 25954938)
21. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
22. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
Colonna L; Andersen HF; Reines EH
Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
[TBL] [Abstract][Full Text] [Related]
24. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.
Schneier FR; Belzer KD; Kishon R; Amsel L; Simpson HB
J Nerv Ment Dis; 2010 Jun; 198(6):458-61. PubMed ID: 20531128
[TBL] [Abstract][Full Text] [Related]
25. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.
Mohr DC; Boudewyn AC; Goodkin DE; Bostrom A; Epstein L
J Consult Clin Psychol; 2001 Dec; 69(6):942-9. PubMed ID: 11777121
[TBL] [Abstract][Full Text] [Related]
26. Change in Seasonal Beliefs Mediates the Durability Advantage of Cognitive-Behavioral Therapy Over Light Therapy for Winter Depression.
Rohan KJ; Burt KB; Norton RJ; Perez J; Iyiewuare P; Terman JM
Behav Ther; 2023 Jul; 54(4):682-695. PubMed ID: 37330257
[TBL] [Abstract][Full Text] [Related]
27. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
Stein DJ; Lopez AG
Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
[TBL] [Abstract][Full Text] [Related]
28. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
29. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
[TBL] [Abstract][Full Text] [Related]
30. A history of early life parental loss or separation is associated with successful cognitive-behavioral therapy in major depressive disorder.
Niciu MJ; Abdallah CG; Fenton LR; Fasula MK; Black A; Anderson GM; Sanacora G
J Affect Disord; 2015 Nov; 187():241-4. PubMed ID: 26363143
[TBL] [Abstract][Full Text] [Related]
31. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
32. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
Jeon HJ; Woo JM; Lee SH; Kim EJ; Chung S; Ha JH; Fava M; Mischoulon D; Kim JH; Heo JY; Yu BH
J Clin Psychopharmacol; 2014 Apr; 34(2):218-25. PubMed ID: 24525660
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
[TBL] [Abstract][Full Text] [Related]
34. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
35. Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder.
Beheydt LL; Schrijvers D; Docx L; Bouckaert F; Hulstijn W; Sabbe B
J Affect Disord; 2015 Dec; 188():47-52. PubMed ID: 26342888
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
37. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Kennedy SH; Andersen HF; Thase ME
Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
[TBL] [Abstract][Full Text] [Related]
38. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
Wade A; Michael Lemming O; Bang Hedegaard K
Int Clin Psychopharmacol; 2002 May; 17(3):95-102. PubMed ID: 11981349
[TBL] [Abstract][Full Text] [Related]
39. Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.
Dunlop BW; Kelley ME; Aponte-Rivera V; Mletzko-Crowe T; Kinkead B; Ritchie JC; Nemeroff CB; Craighead WE; Mayberg HS;
Am J Psychiatry; 2017 Jun; 174(6):546-556. PubMed ID: 28335624
[TBL] [Abstract][Full Text] [Related]
40. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
